Anabolic-weight-gain promoting compositions containing isoflavone derivatives and method using same
AssigneeChinoin Gyogyszer-es Vegyeszeti Termakek Gyara RT
InventorsLaszlo Feuer, Mihaly Nogradi, Agnes Gottsegen, Borbala Vermes, Janos Streliszky, Andreas Wolfner, Lorant Farkas, Sandor Antus, Maria Kovaks
Life of this patent
Estimating the term…
Abstract
A method of anabolic treatment in humans comprises administering a compound of the following formula: ##SPC1## Wherein R is halosubstituted, nitrosubstituted, or unsubstituted benzyl, R.sup.2 is hydrogen, methyl or carboxy, and R.sup.3 and R.sup.4 are hydrogen, methoxy or nitro. Pharmaceutical compositions are also disclosed.
Claims10
An anabolic treatment method for human patients comprising administering to said patients in a daily dosage of 0.2 to 100 mg/kg of body weight a compound having the formula ##SPC11##
- wherein R.sub.1 is halosubstituted, nitrosubstituted or unsubstituted propyl, amyl or benzyl, R.sub.2 is hydrogen, methyl or carboxy and R.sub.3 and R.sub.4 are hydrogen or nitro.
An anabolic treatment method for human patients comprising administering to said patients in a daily dosage of 0.2 to 100 mg/kg of body weight a compound having the formula:
- ##SPC12##
- wherein R.sub.1 is halosubstituted, chlorosubstituted or unsubstituted propyl, amyl or benzyl, R.sub.2 is hydrogen, methyl or carboxy, and R.sub.3 and R.sub.4 are hydrogen, methoxy or nitro.
An anabolic orally administerable pharmaceutical composition which consists essentially of 0.1 part by weight 7-isopropoxyisoflavone, 0.084 parts by weight potato starch, 0.01 part by weight magnesium sterate and 0.006 part by weight polyvinylpyrrolidine.
An anabolic pharmaceutical composition comprising a pharmaceutically acceptable vehicle and an effective amount of a medicament consisting of a compound of the following formula:
- ##SPC13##
- wherein R.sub.1 is halosubstituted, nitrosubstituted or unsubstituted benzyl, R.sub.2 is hydrogen, methyl or carboxy and R.sub.3 and R.sub.4 are hydrogen, methoxy or nitro.
An anabolic pharmaceutical composition comprising a pharmaceutically acceptable vehicle and an effective amount of a medicament consisting of a compound of the following formula:
- ##SPC14##
- wherein R.sub.1 is halosubstituted, nitrosubstituted, or unsubstituted propyl, amyl or benzyl;
- R.sub.2 is hydrogen, methyl or carboxy.
An anabolic pharmaceutical composition comprising an effective amount of a pharmaceutically acceptable vehicle and a medicament consisting of a compound of the following formula:
- ##SPC15##
- wherein R.sub.1 is halosubstituted, chlorosubstituted or unsubstituted propyl, amyl or benzyl and R.sub.2 is hydrogen, methyl or carboxy.
Dependencies are inferred from the claim text.